Literature DB >> 30694

Further characterization of Mycobacterium ulcerans toxin.

W T Hockmeyer, R E Krieg, M Reich, R D Johnson.   

Abstract

Mycobacterium ulcerans produces an exotoxin in culture which, when inoculated into guinea pig skin, causes inflammation, necrosis, edema, and other histopathological changes resembling those in infections of humans. The toxin was resistant to heat and to alkalies and was moderately acid labile. Toxic activity was destroyed by Pronase, phospholipase, lipase, amylase, and glucosidase but not by trypsin, collagenase, cellulase, lysozyme, hyaluronidase, or neuraminidase. Toxic activity was resistant to treatment with 2-mercaptoethanol, urea, guanidine hydrochloride, p-chloromercuribenzoate, ethylenediaminetetraacetate, and sodium deoxycholate but was destroyed by sodium m-periodate and sodium dodecyl sulfate. The toxin was precipitated by a wide range of ammonium sulfate concentrations. Extraction with chlorofrom-methanol or petroleum ether destroyed its activity. Isopycnic density gradient ultracentrifugation in KBr produced a high-density lipoprotein layer with a 24-fold increase in specific activity. The results indicate that this toxin is a high-molecular-weight phospholipoprotein-polysaccharide complex.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30694      PMCID: PMC421965          DOI: 10.1128/iai.21.1.124-128.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  PERIODATE OXIDATION OF THE GLYCOPROTEIN FETUIN.

Authors:  R G SPIRO
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

2.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

3.  The dissociation and reconstitution of aldolase.

Authors:  E STELLWAGEN; H K SCHACHMAN
Journal:  Biochemistry       Date:  1962-11       Impact factor: 3.162

4.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 6.  Mycobacterial lipids: selected topics.

Authors:  M B Goren
Journal:  Bacteriol Rev       Date:  1972-03

7.  Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skin.

Authors:  R E Krieg; W T Hockmeyer; D H Connor
Journal:  Arch Dermatol       Date:  1974-11

8.  Distribution of Mycobacterium ulcerans infections in Zaire, including the report of new foci.

Authors:  W M Meyers; D H Connor; B McCullough; J Bourland; R Moris; L Proos
Journal:  Ann Soc Belg Med Trop       Date:  1974

9.  Cytotoxic activity of Mycobacterium ulcerans.

Authors:  J K Read; C M Heggie; W M Meyers; D H Connor
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

  9 in total
  6 in total

1.  Mycobacterium ulcerans cytotoxicity in an adipose cell model.

Authors:  K M Dobos; P L Small; M Deslauriers; F D Quinn; C H King
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis.

Authors:  T Tønjum; D B Welty; E Jantzen; P L Small
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.

Authors:  K M George; L P Barker; D M Welty; P L Small
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  Biochemical and genetic evidence for phospholipase C activity in Mycobacterium ulcerans.

Authors:  A Gomez; A Mve-Obiang; B Vray; J Remacle; K Chemlal; W M Meyers; F Portaels; P A Fonteyne
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 5.  Emergence of a unique group of necrotizing mycobacterial diseases.

Authors:  K M Dobos; F D Quinn; D A Ashford; C R Horsburgh; C H King
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

Review 6.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.